Oncology Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 250.88 Bn

Forecast Year, 2035

USD 732.45 Bn

CAGR, 2026 - 2035

11.31%

Report Coverage

Global

What is the Oncology Market Size in 2026?

The global oncology market size was calculated at USD 250.88 billion in 2025 and is predicted to increase from USD 279.73 billion in 2026 to approximately USD 732.45 billion by 2035, expanding at a CAGR of 11.31% from 2026 to 2035.

Oncology Market Key Takeaways

• The North America region has reached 46% of the total market share in 2025.
• The cancer treatment segment accounted for 56% of the total market share in 2025.
• By indication, the lung cancer segment registered the maximum market share in 2025.
• The hospital segment is growing at a CAGR of 10.9% from 2026 to 2035.

Oncology Market Growth Factors

The rising oncology burden across the globe owing to the increased consumption of alcohol and tobacco is driving the growth of the global oncology market. The International Agency for Research on Cancer (IARC), in its report GLOBOCAN, has stated that approximately 19.3 million new cancer cases and about 10 million deaths related to cancer were recorded in 2020, across the globe. The IARC has estimated that the new cancer cases are expected to rise by 47% all over the globe from 2020 to 2040. Therefore, the growing prevalence of cancer is expected to foster the adoption of the oncology diagnostics and oncology treatment across the globe, thereby boosting the growth of the global oncology market. Furthermore, the rising initiatives of government and various non-profit organizations in spreading the awareness regarding the prevention of cancer is expected to fuel the growth of the market. For instance, World Health Organization's Global Action Plan for Prevention and Control of Non-Communicable Diseases, aims at decreasing the premature death due to cancer, cardiovascular diseases, chronic respiratory diseases, and diabetes by around 25% by the year 2025. The rising prevalence of the various chronic diseases has augmented the demand for the early diagnostics and treatment of cancer across the globe.

The rising investments and developments in the biopharmaceutical industry is encouraging the development of various innovative drugs and therapeutics, which fosters the demand for the oncology treatment and oncology diagnostics. The growing awareness among the population regarding the availability of various drugs and diagnostics related to oncology is expected to drive the global oncology market growth. The oncology therapeutics alone accounts for around 20% of the global sales of the pharmaceuticals. Therefore, the rising importance and higher potential of profit is attracting the market players to invest in the oncology market.

Market Scope

Segment Insights

Cancer Diagnostics & Treatment Insights

The cancer treatment segment dominated the oncology market in 2025, garnering a market share of around 56%. This is attributable to the increased adoption of the traditional chemotherapy and immunotherapy for the treatment of cancer across the globe. People are now increasingly adopting the targeted therapy and immunotherapy for the treatment as they are more convenient, effective, and has low side-effects as compared to that of the traditional chemotherapy. The low toxicity and the ability of the targeted therapy to specifically target the cancer cells without harming the normal cells is boosting the growth of the cancer treatment segment significantly. Moreover, the rising awareness among the population regarding the benefits of the targeted therapy, hormonal therapy, and the immunotherapy is fueling the demand for these cancer treatments among the global cancer patients.

On the other hand, the cancer diagnostics segment is estimated to be the most opportunistic segment. The increased awareness among the population regarding the cancer disease is augmenting the demand for the cancer diagnostics across the globe. The rising preferences of the people to detect cancer as early as possible is propelling the growth of the cancer diagnostics segment. The availability of various non-invasive and convenient diagnostic tools is expected to drive the growth of this segment during the forecast period.

Indication Insights

The lung cancer segment dominated the market in 2025, owing to the increased cases of lungs cancer across the globe. According to the International Agency for Research on Cancer, around 1.8 million deaths were recorded due to lungs cancer in 2020. Lungs cancer is the most diagnosed type of cancer among the global population and it accounts for around 18% of the cancer deaths all over the globe. It is recognized as the leading cause of cancer deaths. The increased prevalence of smoking around the globe is a major factor that boosts the growth of this segment.

Breast cancer, on the other hand, is anticipated to be the fastest-growing market during the forecast period. This is due to the growing prevalence of the breast cancer among the female population. As per the IARC, breast cancer has surpassed the lungs cancer as the most diagnosed type of cancer in 2020. Around 2.3 million or 11.7% of the new cancer cases reported as the breast cancer in 2020.

Regional Insights

U.S. Oncology Market Size and Growth 2026 to 2035

The U.S. oncology market size was estimated at USD 81.26 billion in 2025 and is predicted to be worth around USD 241.69 billion by 2035, at a CAGR of 11.52% from 2026 to 2035.

North America dominated the global oncology market in 2025. This can be attributed to the increased prevalence of cancer in the major market like US. According to the American Cancer Society, over 1.8 million new cancer cases and 606,520 deaths were reported in the US in 2020. The most prominent type of cancer in North America includes lungs cancer, colorectal cancer, breast cancer, and the prostate cancer. The North America oncology market is expected to sustain its significance owing to the presence of developed healthcare infrastructure and the increased healthcare expenditure. The increased adoption of the oncology treatments in US has resulted in a decline of cancer deaths by around 29% since 1991.

U.S. Market Trends

CAR-T is one of the cutting-edge treatments for advanced cancer that is increasingly being provided at outpatient and home locations with the support of telemedicine and telehealth monitoring in the U.S. Improving patient care coordination with AI on digital platforms and reducing treatment delays. Other promising developments in the market include the antibody-drug conjugates (ADC) and bispecific antibody therapeutics in the field of cancer diagnosis and treatment.

Europe is anticipated to be the most opportunistic market during the forecast period. This is attributable to the rising technological advancements in the diagnostics of various cancers. Moreover, the rising prevalence of cancer across Europe and growing number of cancer deaths is expected to foster the growth of the Europe oncology market in the forthcoming years.According to the European Commission, approximately 2.7 million new cancer cases and about 1.3 million cancer deaths were recorded in 2020.

Germany Market Trends

In Germany, the personalization of cancer treatment is gaining in popularity through the use of advanced cancer diagnostics such as molecular tumor sequencing and next-generation imaging. The country is still stressing the strict standards of certification for specialized cancer centres to ensure the quality of treatment. Combination immunotherapies and antibody-drug conjugates are also becoming more important in the treatment of breast cancer and other oncology applications.

Asia Pacific is expected to grow significantly in the oncology market during the forecast period. The increasing cancer cases in the Asia Pacific are increasing the demand for early diagnosis as well as treatment options for effective management. This, in turn, increases the research and development in the field of oncology. Moreover, this also increases the collaboration between companies and institutes for enhancing the development of new diagnostic and treatment approaches. Furthermore, the advancing healthcare sectors are also adopting various technologies, which are enhancing the development as well as the production process. Thus, all these factors, along with the government and regulatory bodies' support, enhance the market growth.

China Market Trends

China is making a rapid transition to the new category of drugs, such as CAR-T, immunotherapies, and antibody-drug conjugates, from traditional oncology drugs. There is increased acceleration of treatments to patients and better regulatory pathways for new treatments for cancer. There is also increasing overall competition in the older generic drugs business, and Chinese biotech companies are strengthening their worldwide licences as well.

What Are the Driving Factors of The Oncology Market in Latin America?

Latin America is expected to grow at a significant CAGR during the forecast period. The oncology market in Latin America is growing due to rising cancer awareness, easy access to diagnostic solutions, and rising preference for private healthcare services. But access to more sophisticated targeted therapy continues to be hampered by the high cost of treatment and by unequal access.

Brazil Market Trends

There is a continuous improvement in the availability of specific cancer drugs or molecular tests in Brazil. Investments in cancer-specific centres, however, have helped to build up infrastructure for treatment, especially for breast and colorectal cancer. Progress is also being made on the regulatory front with quicker access to innovative oncology products, but there are disparities in public versus private healthcare access.

How is the Middle East and Africa Performing in The Oncology Market?

The Middle East and Africa are expected to grow at a significant CAGR during the forecast period. The rising incidence of cancer, improved healthcare infrastructure, and the modernization of oncology services are driving the growth in the market. The market is growing due to the rising incidences of cancer, the improvement of healthcare facilities, and the modernization of oncology services. The demand for cutting-edge cancer treatment and AI-based diagnostics is rapidly growing in the GCC region.

Nigeria Market Trends

In Nigeria, there are efforts towards enhancing investments in pathology services and early detection technologies for better survival rates. Access to advanced radiotherapy equipment is being scaled up with the involvement of public-private partnerships. Lack of oncologists also means that the health systems are now educating nursing staff and GPs in some basic palliative care and patient support services.

Some Sales Insight Revealing the Strong Growth of Oncology During the Past Few Years are Listed Below:

• In the last five years, 64 oncology new active substances have been launched across the globe
• The cancer treatment segment accounted for around 56% of the global oncology market share in 2020
• About 19.3 million new cancer cases and around 10 million deaths related to cancer were registered in 2020
• New cancer cases are expected to rise by 47% from 2020 to 2040, across the globe
• Approximately 1.8 million deaths were recorded due to lungs cancer in 2020
• Approximately 2.3 million or 11.7% of the new cancer cases were breast cancer in 2020

Oncology Market Companies

• Aegerion Pharmaceuticals Inc.
• Abbvie Inc.
• Ability Pharma
• Acadia Pharmaceuticals Inc.
• Amgen Inc.
• Takeda Oncology
• Aslan Pharmaceuticals Ltd.
• Aspen Pharmacare Holdings Limited.
• Astrazeneca
• Athenex, Inc.

Segments Covered in the Report

By Cancer Diagnostics & Treatment

• Cancer Diagnostics
  • Biopsy
  • Imaging
  • Immunohistochemistry
  • Tumor Biomarkers Test
  • In Situ Hybridization
  • Liquid Biopsy
• Cancer Treatment
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy
  • Immunotherapy
  • Others

By Indication

• Lungs Cancer
• Colorectal Cancer
• Breast Cancer
• Liver Cancer
• Bladder Cancer
• Head & Neck Cancer
• Prostate Cancer
• Others

By End-use

• Hospitals
• Diagnostic laboratories
• Diagnostic imaging centers
• Academia
• Specialty clinics
• Others

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• MEA
• Rest of the World